Exact Sciences (EXAS) Revenue (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Revenue data on file, last reported at $878.4 million in Q4 2025.

• Revenue for Q4 2025 came in at $878.4 million, up 23.12% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 billion (up 17.69% YoY), and the FY2025 annual result was $3.2 billion, up 17.69% from the prior year.
• Revenue advanced to $878.4 million in Q4 2025 per EXAS's latest filing, from $850.7 million in the prior quarter.
• Over five years, Revenue peaked at $878.4 million in Q4 2025 and troughed at $402.1 million in Q1 2021.
• A 5-year average of $617.8 million and a median of $625.2 million in 2023 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 61.72% in 2021 and fell as far as 1.6% in 2021.
• A 5-year view of Revenue shows it stood at $473.8 million in 2021, then grew by 16.71% to $553.0 million in 2022, then grew by 16.98% to $646.9 million in 2023, then gained by 10.29% to $713.4 million in 2024, then increased by 23.12% to $878.4 million in 2025.
• Business Quant data shows EXAS's Revenue at $878.4 million in Q4 2025, $850.7 million in Q3 2025, and $811.1 million in Q2 2025.